FIBRINOLYTICS TREATMENT FOR BLOOD CLOTS
Lumbrokinase, serrapeptase and nattokinase are proteolytic enzymes that act as natural anticoagulants by breaking down fibrin that forms blood clots.
Fibrinolytic enzymes are antihypertensive, anti-atherosclerotic, lipid-lowering and anti-platelet agents, which also have neuroprotective effects.
Nattokinase at a dose of 10,800 units a day for 12 months “effectively managed the progression of atherosclerosis and hyperlipidemia” in one study.
Just one 2,000 FU dose of nattokinase enhanced fibrinolysis and anti-coagulation, activating multiple fibrinolytic and anti-thrombotic pathways simultaneously.
Lumbrokinase is nearly 30 times stronger than nattokinase and 300 times stronger than serrapeptase.
#bloodclot #clots #Fibrinolytics #Fibrin